Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Glioma 3 Brain Neoplasms 3 Neuroectodermal Tumors 2 Nervous System Diseases 2 Neoplasms, Neuroepithelial 2 Neoplasms, Nerve Tissue 2 Gliosarcoma 2 Sarcoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Histologic Type 1 Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Disease 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Carcinoma 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 115 Radiotherapy 63 Magnetic Resonance Spectroscopy 30 Carboplatin 30 Bevacizumab 30 Carmustine 28 Filgrastim 23 Surgical Procedures, Operative 22 Irinotecan 22 Radiation 18 Lomustine 17 Vincristine 15 Etoposide 15 Specimen Handling 13 Peripheral Blood Stem Cell Transplantation 13 O(6)-benzylguanine 13 Radiotherapy, Intensity-Modulated 12 Procarbazine 11 Erlotinib Hydrochloride 11 Cyclophosphamide 11 Chemotherapy, Adjuvant 11 sargramostim 10 Thiotepa 10 Cisplatin 10 Flucytosine 9 Everolimus 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Granulocyte Colony-Stimulating Factor 8 Vorinostat 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × Oncolytic Virotherapy × CNS × Clear all

NCT06283927 2024-02-28

RECSUR

Erasmus Medical Center

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡